ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,770.20
0.55%
Dow Jones
42,801.72
0.52%
US Dollar vs MXN
20.26717
0.00%
Brent Oil
70.235
0.00%
Bitcoin
83,294.70
-3.32%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) Noticias

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:NBY
FechaHoraFuenteTítuloSímboloCompañía
07/03/202506:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
07/03/202506:07Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
18/02/202516:25Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:NBYNovaBay Pharmaceuticals Inc New
06/02/202517:30Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
23/01/202507:00Business WireNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution ProposalAMEX:NBYNovaBay Pharmaceuticals Inc New
10/01/202517:06Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:NBYNovaBay Pharmaceuticals Inc New
19/12/202405:50Business WireNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersAMEX:NBYNovaBay Pharmaceuticals Inc New
09/12/202405:50Business WireNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special MeetingAMEX:NBYNovaBay Pharmaceuticals Inc New
22/11/202415:05Business WireNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
15/11/202407:00Business WireProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova BrandAMEX:NBYNovaBay Pharmaceuticals Inc New
08/11/202416:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202415:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202415:05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
06/11/202415:05Business WireNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase PriceAMEX:NBYNovaBay Pharmaceuticals Inc New
29/10/202407:00Business WireNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCAMEX:NBYNovaBay Pharmaceuticals Inc New
16/10/202415:19Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
25/09/202416:17Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
23/09/202408:27PR Newswire (US)Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law FirmAMEX:NBYNovaBay Pharmaceuticals Inc New
20/09/202407:30PR Newswire (US)Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsAMEX:NBYNovaBay Pharmaceuticals Inc New
20/09/202407:00Business WireNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova AssetsAMEX:NBYNovaBay Pharmaceuticals Inc New
13/08/202415:05Business WireNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
01/08/202405:50Business WireNovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
30/07/202405:50Business WireNovaBay Pharmaceuticals Reports Record Amazon Prime Day SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
29/07/202415:05Business WireNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionAMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202416:19Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202407:30Business WireNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingAMEX:NBYNovaBay Pharmaceuticals Inc New
25/07/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NBYNovaBay Pharmaceuticals Inc New
16/07/202405:50Business WireNovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime DayAMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/202407:50Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/202405:50Business WireNovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 MillionAMEX:NBYNovaBay Pharmaceuticals Inc New
 Showing the most relevant articles for your search:AMEX:NBY

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
USOTC
RHHBY
Roche (QX)
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
COIN
AVAXUSD
Avalanche
CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
NYSE
AXP
American Express
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios